Tissue Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments and Reagents, and Consumables), By Application (Breast Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers), By Technology (Immunohistochemistry, In-Situ Hybridizations, Digital Pathology and Workflow Management, and Others), By Region and Competition 2018-2028

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

 

Forecast Period

2024-2028

Market Size (2022)

USD 5.11 billion

CAGR (2023-2028)

7.36%

Fastest Growing Segment

Instruments and Reagents

Largest Market

North America

 

Market Overview

Global Tissue Diagnostics Market has valued at USD 5.11 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 7.36% through 2028. The Global Tissue Diagnostics Market represents a critical segment within the broader field of healthcare diagnostics. It encompasses a wide range of techniques and technologies used to examine tissues and cells for the detection, diagnosis, and monitoring of diseases, particularly cancer. The market is driven by several key factors, including the rising incidence of cancer worldwide, the growing aging population, and the increasing demand for precise and personalized medicine. Tissue diagnostics techniques include immunohistochemistry, in situ hybridization, digital pathology, and special staining, among others. These tools aid pathologists and healthcare professionals in identifying disease markers, evaluating tissue abnormalities, and determining the most appropriate treatment strategies for patients. Furthermore, the integration of artificial intelligence (AI) and machine learning in tissue diagnostics is enhancing the accuracy and efficiency of analysis, enabling faster and more accurate disease detection and classification. While North America has traditionally been a prominent market due to high healthcare expenditures and advanced technology adoption, emerging economies in Asia-Pacific are also witnessing substantial growth, driven by expanding healthcare infrastructure and increasing awareness. The tissue diagnostics market continues to evolve, with ongoing research and development efforts aimed at improving diagnostic accuracy, expanding applications, and optimizing patient care, making it a vital component of modern healthcare systems globally.

Key Market Drivers

Increasing Cancer Incidence

The increasing cancer incidence is a significant driver in the Global Tissue Diagnostics Market. Cancer has become a pressing global health concern, with rising incidence rates observed across the world. This surge in cancer cases underscores the critical role of tissue diagnostics in disease detection, characterization, and treatment planning. Tissue diagnostics techniques, such as histopathology and immunohistochemistry, are fundamental in confirming cancer diagnoses, determining cancer type and stage, and assessing the aggressiveness of the disease. As cancer rates continue to climb due to factors like lifestyle changes, aging populations, environmental factors, and genetic predisposition, the demand for tissue diagnostics escalates in parallel. Moreover, advancements in tissue-based molecular testing have enabled the identification of specific biomarkers that guide targeted therapies, further emphasizing the importance of tissue diagnostics in cancer treatment. The ongoing battle against cancer necessitates accurate and timely tissue analysis, making tissue diagnostics an indispensable tool in the fight against this widespread and complex disease. As a result, the tissue diagnostics market is poised for sustained growth, driven by the ever-increasing demand for effective cancer diagnosis and management on a global scale.

Advancements in Technology

Advancements in technology have played a pivotal role in driving innovation and growth in the Global Tissue Diagnostics Market. These technological developments have significantly enhanced the precision, efficiency, and accessibility of tissue diagnostics, making them more indispensable than ever in the field of healthcare. Digital pathology is one such advancement, allowing for the digitization of histopathological slides, enabling remote access, and facilitating collaborative consultations among pathologists. Artificial intelligence (AI) and machine learning have also emerged as game-changers, automating image analysis, improving diagnostic accuracy, and helping identify subtle patterns and biomarkers that might be missed by the human eye. Furthermore, the integration of molecular techniques like polymerase chain reaction (PCR) and next-generation sequencing (NGS) into tissue diagnostics enables the detection of specific genetic mutations, gene expression profiles, and protein markers, aiding in precise disease characterization and personalized treatment decisions. These technological strides have not only expedited the diagnostic process but have also paved the way for more comprehensive and tailored patient care. As technology continues to evolve, tissue diagnostics are likely to become even more sophisticated and integral to the diagnosis and management of a wide range of diseases, further advancing the global tissue diagnostics market.

Increasing Healthcare Expenditure

The increasing healthcare expenditure is a significant factor influencing the growth of the Global Tissue Diagnostics Market. Globally, governments, healthcare institutions, and individuals are dedicating a larger portion of their financial resources to healthcare services and technologies. This surge in healthcare spending reflects the growing awareness of the importance of early disease detection and precise diagnostics, particularly in the context of complex diseases like cancer. Tissue diagnostics, which play a pivotal role in disease diagnosis, staging, and treatment planning, are beneficiaries of this increased expenditure. As healthcare budgets expand, healthcare providers can invest in advanced tissue diagnostic equipment, cutting-edge technologies, and skilled personnel, ensuring better accessibility and higher quality diagnostic services. Moreover, with greater financial resources allocated to research and development in the healthcare sector, there is ongoing innovation in tissue diagnostics, leading to the development of more accurate and efficient diagnostic tests and techniques. The increasing healthcare expenditure is, therefore, not only driving the demand for tissue diagnostics but also fostering an environment of continuous improvement and innovation in this crucial segment of the healthcare industry, ultimately benefiting patients through earlier, more accurate, and more effective disease management.

Awareness and Screening Programs

Awareness and screening programs play a vital role in shaping the Global Tissue Diagnostics Market. These initiatives are designed to raise public consciousness about the importance of early disease detection and encourage individuals to undergo regular health screenings. In particular, awareness campaigns and organized screening programs for diseases such as cancer, including breast, cervical, colorectal, and prostate cancers, have been instrumental in driving the demand for tissue diagnostics. As these programs emphasize the benefits of early diagnosis, more individuals seek medical attention, resulting in an increased volume of tissue samples requiring analysis. Tissue diagnostics, including techniques like histopathology and immunohistochemistry, are critical components of these screening programs, as they confirm diagnoses, provide valuable insights into disease progression, and guide appropriate treatment strategies. The success of these programs is further bolstered by technological advancements in tissue diagnostics, which enhance accuracy and speed in disease detection. By fostering a culture of proactive health management and early intervention, awareness and screening programs contribute significantly to the growth of the tissue diagnostics market, ensuring that diseases are identified and managed at their earliest, most treatable stages, ultimately improving patient outcomes and reducing the burden of advanced diseases on healthcare systems worldwide.


Download Free Sample Report

 

Key Market Challenges

High Cost of Equipment

The high cost of equipment is a significant restraining factor in the Global Tissue Diagnostics Market. Tissue diagnostic technologies, including advanced imaging systems, digital pathology scanners, molecular testing platforms, and automated tissue processors, often come with a substantial price tag. The initial capital investment required to acquire and install these machines can strain the budgets of healthcare institutions, particularly smaller clinics and facilities in resource-constrained regions. Moreover, the ongoing maintenance and service costs can add to the financial burden. This cost factor can deter healthcare providers from adopting or upgrading tissue diagnostic equipment, leading to outdated infrastructure that hampers diagnostic accuracy and efficiency. In addition, the affordability of tissue diagnostic services for patients can be compromised when healthcare providers pass on the high equipment costs through service fees. Addressing the high cost of equipment is essential to ensure equitable access to tissue diagnostics globally. Efforts to reduce costs, such as the development of more cost-effective diagnostic platforms and public-private partnerships, are crucial in making tissue diagnostics more accessible to healthcare providers and patients alike, thereby overcoming this significant restraint in the market.

Limited Accessibility in Developing Regions

Limited accessibility in developing regions is a significant challenge facing the Global Tissue Diagnostics Market. In many low-resource and underserved areas of developing countries, access to tissue diagnostics is constrained by various factors. Firstly, there is a shortage of well-equipped healthcare facilities with the necessary infrastructure and skilled personnel to perform tissue diagnostics accurately. Secondly, the high cost of diagnostic equipment, reagents, and maintenance can be prohibitive for healthcare institutions with limited budgets. Thirdly, geographical barriers and inadequate transportation infrastructure can impede patients' ability to reach healthcare centers that offer tissue diagnostic services, especially in remote rural areas. Additionally, a lack of awareness and education about the importance of early disease detection can lead to delayed healthcare-seeking behavior. Addressing limited accessibility in developing regions requires multifaceted efforts, including investments in healthcare infrastructure, training programs to build a skilled workforce, development of affordable and portable diagnostic technologies, and public health campaigns to raise awareness and encourage regular screenings. Overcoming these accessibility challenges is essential for ensuring that individuals in underserved regions have equitable access to tissue diagnostics, leading to earlier disease detection and improved healthcare outcomes.

Key Market Trends

Digital Pathology and AI Integration

Digital Pathology and AI Integration is a transformative trend in the Global Tissue Diagnostics Market. Digital pathology involves the digitization of traditional glass slides, enabling pathologists and healthcare professionals to view and analyze high-resolution histopathological images electronically. This shift from traditional microscopy to digital platforms allows for remote access, streamlined collaborations, and the creation of vast image archives. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms enhances the diagnostic capabilities of digital pathology. AI-powered image analysis software can assist pathologists in identifying and quantifying tissue abnormalities, identifying specific biomarkers, and even predicting disease outcomes. These technologies improve diagnostic accuracy, reduce the risk of human error, and enable faster turnaround times, ultimately leading to more efficient and precise tissue diagnostics. Furthermore, AI-driven predictive analytics can help pathologists make more informed treatment recommendations by considering vast datasets and identifying subtle patterns that might be missed by the human eye. As the adoption of digital pathology and AI continues to grow, it not only enhances the quality of tissue diagnostics but also facilitates the development of large-scale databases for research and the delivery of pathology services to underserved areas through telepathology, making it a pivotal trend in advancing the field of tissue diagnostics.

Growing Telepathology

Telepathology is a crucial trend in the Global Tissue Diagnostics Market, revolutionizing the way pathology services are delivered and accessed. This approach involves the remote consultation and interpretation of pathology specimens, primarily histopathological images, by pathologists located at a distance from the patient or the specimen source. Telepathology leverages digital technology and high-speed internet connectivity to transmit high-resolution images, clinical data, and patient histories to remote pathologists for analysis. This trend offers several significant advantages, including improved access to specialized expertise and consultations regardless of geographical boundaries. It enhances collaboration among pathologists and facilitates second opinions on complex cases, ultimately leading to more accurate diagnoses and treatment decisions. Additionally, telepathology has proven particularly valuable in underserved and remote regions where access to experienced pathologists may be limited. It also supports healthcare systems in managing workloads efficiently by enabling pathologists to review cases remotely, thereby reducing turnaround times and enhancing overall patient care. As the demand for pathology services continues to grow, telepathology plays a pivotal role in addressing challenges related to access, expertise, and timely diagnosis, making it a transformative trend in the field of tissue diagnostics.

Segmental Insights

Application Insights

In 2022, the Tissue Diagnostics Market was dominated by the breast cancer segment and is predicted to continue expanding over the coming years. This is attributed due to the rising prevalence of cancer across various regions in the world, growing advanced technologies, and rising research initiatives.


Download Free Sample Report

Regional Insights

In 2022, the Global Tissue Diagnostics Market was dominated by the North America segment and is predicted to continue expanding over the coming years. This is ascribed due to rising cases cancer cases, rising development of cancer technology, and the growing healthcare infrastructure.

Recent Development

  • In June 2022, F. Hoffmann La Roche announced the CE launch of the next-generation VENTANA DP 600 slide scanner. This high-capacity slide scanner produces excellent image quality of stained histology slides from patient tissue samples, which provides ease of use and workflow flexibility for the pathology lab.
  • In March 2021, The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy was launched by IZI Medical Products LLC ("IZI"), a prominent developer of medical devices used in interventional radiology and interventional oncology treatments. The Quick-Core Auto is a lightweight, automatic biopsy equipment that adds to the reliability, precision, and quality of IZI's Quick-Core semi-automatic biopsy system.

Key Market Players

  • Nanoscribe GmbH & Co. KG
  • Stratasys Ltd.
  • 3D Systems Inc.
  • EOS GmbH
  • Renishaw PLC
  • Exone Company.
  • Formlabs Inc.,
  • Materialise NV.
  • SLM Solutions Group AG
  • Oxferd Performance Materials, Inc.

By Product

By Application

By Technology

By Region
  • Instruments and Reagents Consumables
  • Circulating Tumor Cells
  • Circulating Tumor DNA
  • Cell-free DNA
  • Immunohistochemistry
  • In-Situ Hybridizations
  • Digital Pathology
  • Workflow Management
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Tissue Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Tissue Diagnostics Market, By Product:

o   Instruments and Reagents Consumables

  • Global Tissue Diagnostics Market, By Application:

o   Circulating Tumor Cells

o   Circulating Tumor DNA

o   Cell-free DNA

  • Global Tissue Diagnostics Market, By Technology:

o   Immunohistochemistry

o   In-Situ Hybridizations

o   Digital Pathology

o   Workflow Management

o   Others

  • Global Tissue Diagnostics Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tissue Diagnostics Market.

Available Customizations:

Global Tissue Diagnostics Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Global Tissue Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Global Tissue Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Instruments and Reagents, and Consumables)

5.2.2.     By Application (Breast Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers)

5.2.3.     By Technology (Immunohistochemistry, In-Situ Hybridizations, Digital Pathology and Workflow Management, and Others)

5.2.4.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.5.     By Company (2022)

5.3.  Product Market Map

5.3.1.     By Product

5.3.2.     By Application

5.3.3.     By Technology

5.3.4.     By Region

6.    North America Tissue Diagnostics Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product

6.2.2.     By Application

6.2.3.     By Technology

6.2.4.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Tissue Diagnostics Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product

6.3.1.2.2.             By Application

6.3.1.2.3.             By Technology

6.3.2.     Canada Tissue Diagnostics Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product

6.3.2.2.2.             By Application

6.3.2.2.3.             By Technology

6.3.3.     Mexico Tissue Diagnostics Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product

6.3.3.2.2.             By Application

6.3.3.2.3.             By Technology

7.    Europe Tissue Diagnostics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Application

7.2.3.     By Technology

7.2.4.     By Country

7.3.  Europe: Country Analysis

7.3.1.     Germany Tissue Diagnostics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Application

7.3.1.2.3.             By Technology

7.3.2.     France Tissue Diagnostics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Application

7.3.2.2.3.             By Technology

7.3.3.     United Kingdom Tissue Diagnostics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Application

7.3.3.2.3.             By Technology

7.3.4.     Italy Tissue Diagnostics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Application

7.3.4.2.3.             By Technology

7.3.5.     Spain Tissue Diagnostics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Application

7.3.5.2.3.             By Technology

8.    Asia-Pacific Tissue Diagnostics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Application

8.2.3.     By Technology

8.2.4.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Tissue Diagnostics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Application

8.3.1.2.3.             By Technology

8.3.2.     Japan Tissue Diagnostics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Application

8.3.2.2.3.             By Technology

8.3.3.     India Tissue Diagnostics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Application

8.3.3.2.3.             By Technology

8.3.4.     South Korea Tissue Diagnostics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Application

8.3.4.2.3.             By Technology

8.3.5.     Australia Tissue Diagnostics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Application

8.3.5.2.3.             By Technology

9.    South America Tissue Diagnostics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Application

9.2.3.     By Technology

9.2.4.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Tissue Diagnostics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Application

9.3.1.2.3.             By Technology

9.3.2.     Argentina Tissue Diagnostics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Application

9.3.2.2.3.             By Technology

9.3.3.     Colombia Tissue Diagnostics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Application

9.3.3.2.3.             By Technology

10.  Middle East and Africa Tissue Diagnostics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Application

10.2.3.  By Technology

10.2.4.  By Country

10.3.              MEA: Country Analysis

10.3.1.  UAE Tissue Diagnostics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Application

10.3.1.2.3.           By Technology

10.3.2.  Saudi Arabia Tissue Diagnostics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Application

10.3.2.2.3.           By Technology

10.3.3.  South Africa Tissue Diagnostics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Application

10.3.3.2.3.           By Technology

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Merger & Acquisition

12.2.              Product Development

12.3.              Recent Developments

13.  Porter’s analysis

14.  PESTEL analysis

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Company Snapshot

15.3.              Products & Services

15.4.              Financials (As Reported)

15.5.              Recent Developments

15.5.1.  Nanoscribe GmbH & Co. KG

15.5.2.  Stratasys Ltd.

15.5.3.  3D Systems Inc.

15.5.4.  EOS GmbH

15.5.5.  Renishaw PLC

15.5.6.  Exone Company.

15.5.7.  Formlabs Inc.,

15.5.8.  Materialise NV.

15.5.9.  SLM Solutions Group AG

15.5.10.                Oxferd Performance Materials, Inc.

16. Strategic Recommendations 

Figures and Tables

Frequently asked questions

down-arrow

The Market size of the Global Tissue Diagnostics Market was estimated to be USD 5.11 billion in 2022.

down-arrow

Nanoscribe GmbH & Co. KG, Stratasys Ltd., 3D Systems Inc., EOS GmbH, Renishaw PLC, Exone Company, Formlabs Inc., Materialise NV, SLM Solutions Group AG, Oxferd Performance Materials, Inc etc. are some of the key players operating in the Global Tissue Diagnostics Market.

down-arrow

Regulatory Challenges, reimbursement policies for tissue diagnostics may be limited or inconsistent, are some of the major challenges faced by the Global Tissue Diagnostics Market in the upcoming years.

down-arrow

Public awareness campaigns and organized screening programs for diseases like breast and cervical cancer etc. are the major drivers for the Global Tissue Diagnostics Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Tissue Diagnostics Market to Grow with a CAGR of 7.36% through 2028

Sep, 2023

Rising incidences of cancer are expected to drive the Global Tissue Diagnostics Market in the forecast period 2024-2028.

Why Choose Us